Skip to main content
Premium Trial:

Request an Annual Quote

GeneTrace Gets Genomics Grants from NCI and NIEH


ALAMEDA, Calif.--GeneTrace Systems has been awarded two Small Business Innovation Research grants to conduct functional genomics studies. The US National Institute of Environmental Health Sciences has supplied a grant for the further development of the company's high-throughput single-nucleotide polymorphism analysis capabilities using mass spectrometry. The goal is to evaluate human samples for polymorphisms in genes that may modify the risk of disease in response to environmental factors.

Another US government organization, the National Cancer Institute, is funding gene expression monitoring of multiplexed cancer gene sets and their responses to changes in their environment as part of the institute's Cancer Genome Anatomy Project. One difficulty in cancer cell analysis is the propensity for each tumor to have unique mutations. These differences are reflected in the expression of RNA and proteins in cancer cells. GeneTrace's high-throughput expression capability will be applied to the comprehensive molecular characterization of normal, precancerous, and malignant cells, evaluating multiple genes in many samples.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.